Prof Michael Douek speaks to ecancer at BGICC 2019 in Cairo about neoadjuvant chemotherapy in breast cancer.

He weighs up the main issues for surgeons, breast conservation, and when primary chemotherapy is necessary.

Prof Douek emphasises that there needs to be more level one evidence to support the use of neoadjuvant chemotherapy.